|
- VENCLEXTA® (venetoclax tablets): CLL SLL and AML Treatment
Discover VENCLEXTA® (venetoclax tablets): An oral therapy to help you fight certain blood cancers See full Prescribing and Safety information
- How Does VENCLEXTA® (venetoclax tablets) Work?
VENCLEXTA is designed to be completed in a set amount of time (12 months for previously untreated CLL SLL when combined with GAZYVA or about 24 months for previously treated CLL SLL when combined with rituximab), unlike some other oral therapies that you take until your disease progresses
- How VENCLEXTA® May Help | VENCLEXTA® for Untreated CLL SLL
Learn how VENCLEXTA (venetoclax tablets) combined with GAZYVA may help treat CLL SLL in previously untreated patients See full Prescribing Safety Info
- VENCLEXTA® + GAZYVA® Dosing Schedule
Discover the CLL SLL treatment dosing schedule for VENCLEXTA (venetoclax tablets) in combination with GAZYVA See full Prescribing and Safety information
- Possible Side Effects | VENCLEXTA® for Untreated CLL SLL
See the possible side effects of VENCLEXTA® (venetoclax tablets) that untreated CLL SLL patients need to be aware of See full Prescribing and Safety info
- What is VENCLEXTA® (venetoclax tablets)? | AML Treatment
VENCLEXTA is a prescription medicine used in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly diagnosed acute myeloid leukemia (AML) who:
- How Its Different - VENCLEXTA® for Untreated CLL SLL
See what makes VENCLEXTA® (venetoclax tablets) different from other CLL SLL treatments Chemo-free, completed in ~12 months See full Safety Prescribing Info
- VENCLEXTA patient calendar
VENCLEXTA is a prescription medicine used to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) It is not known if VENCLEXTA is safe and effective in children Safety Considerations umor lysis syndrome (TLS) TLS can cause kidney failure, the need for dialysis treatm nt, and may lead to death Your
|
|
|